FDA to launch advisory committee on digital health technologies
The Food and Drug Administration will accept nominations through Dec. 11 for experts to serve on a committee that will advise the agency on issues related to digital health technologies, from artificial intelligence/machine learning and digital therapeutics to wearables and remote patient monitoring.
“Many of these technologies are novel and tend to rapidly change; it’s our duty to seek as much knowledge on them as possible as we determine and implement appropriate regulation to encourage innovation while protecting public health,” said Troy Tazbaz, director of the FDA’s Digital Health Center of Excellence.
Related News Articles
Headline
New guidance from the Cybersecurity and Infrastructure Security Agency encourages healthcare organizations to consider internal network and internet facing…
Headline
The National Institute of Standards and Technology and the Cybersecurity and Infrastructure and Security Agency have released guidelines to protect…
Headline
The House Energy and Commerce Subcommittee on Health held a hearing Sept. 15 to discuss more than a dozen legislative proposals regarding Medicare provider…
Headline
The National Security Agency has released a best practices guide on effective cyber hygiene for defending against advanced cyber threats, including those…
Headline
An FBI alert released Sept. 1 warns of cyber actors impersonating government officials, media and other public individuals on a commercial messaging app to…
Headline
In this conversation, John Riggi, AHA national advisor for cybersecurity and risk, and Scott Gee, AHA deputy national advisor for cybersecurity and risk, break…